8-K
filed July 15, 2026, 5:36 PM ET
ticker CPRX
CIK 0001369568
M&A
confidence high
sentiment neutral
materiality 1.00
Catalyst Pharmaceuticals completes merger with Angelini Pharma; shareholders receive $31.50/share
CATALYST PHARMACEUTICALS, INC.
- Merger closed July 15, 2026; each share converted to $31.50 cash, no interest.
- Stock to be delisted from Nasdaq; trading suspended July 16, 2026.
- All directors resigned; new directors from Angelini (Sergio Marullo di Condojanni, Massimo Marin, Enrica Dogali) appointed.
- Certificate of incorporation and bylaws amended and restated.
- Company becomes wholly owned subsidiary of Angelini Pharma S.p.A.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
David S. Tierney, M.D. resigned as Director at CATALYST PHARMACEUTICALS, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) resigned and ceased to be directors of the board of directors of the Company and members of any committee thereof, as applicable.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Enrica Dogali was appointed as Director at CATALYST PHARMACEUTICALS, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
the directors of Merger Sub immediately prior to the Effective Time (Sergio Marullo di Condojanni; Massimo Marin; Enrica Dogali) became the directors of the Surviving Corporation.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Daniel J. Curran, M.D. resigned as Director at CATALYST PHARMACEUTICALS, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) resigned and ceased to be directors of the board of directors of the Company and members of any committee thereof, as applicable.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Massimo Marin was appointed as Director at CATALYST PHARMACEUTICALS, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
the directors of Merger Sub immediately prior to the Effective Time (Sergio Marullo di Condojanni; Massimo Marin; Enrica Dogali) became the directors of the Surviving Corporation.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Molly Harper resigned as Director at CATALYST PHARMACEUTICALS, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) resigned and ceased to be directors of the board of directors of the Company and members of any committee thereof, as applicable.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Tamar Thompson resigned as Director at CATALYST PHARMACEUTICALS, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) resigned and ceased to be directors of the board of directors of the Company and members of any committee thereof, as applicable.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Patrick J. McEnany resigned as Director at CATALYST PHARMACEUTICALS, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) resigned and ceased to be directors of the board of directors of the Company and members of any committee thereof, as applicable.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Donald A. Denkhaus resigned as Director at CATALYST PHARMACEUTICALS, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) resigned and ceased to be directors of the board of directors of the Company and members of any committee thereof, as applicable.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Sergio Marullo di Condojanni was appointed as Director at CATALYST PHARMACEUTICALS, INC..
- Action
- appointed
- Role
- Director
Exact text from the filing
the directors of Merger Sub immediately prior to the Effective Time (Sergio Marullo di Condojanni; Massimo Marin; Enrica Dogali) became the directors of the Surviving Corporation.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Richard J. Daly resigned as Director at CATALYST PHARMACEUTICALS, INC..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) resigned and ceased to be directors of the board of directors of the Company and members of any committee thereof, as applicable.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.